Survival of Coronavirus in Different Cities, on Different Surfaces

Temperature, humidity, surface play roles in the drying time of COVID-19 virus respiratory droplets
American Institute of Physics (AIP)

Newswise — WASHINGTON, June 9, 2020 -- One of the many questions researchers have about COVID-19 is how long the coronavirus causing the disease remains alive after someone infected with it coughs or sneezes. Once the droplets carrying the virus evaporate, the residual virus dies quickly, so the survival and transmission of COVID-19 are directly impacted by how long the droplets remain intact.

In a paper in Physics of Fluids, by AIP Publishing, researchers examine the drying time of respiratory droplets from COVID-19-infected subjects on various surfaces in six cities around the world. These droplets are expelled from the mouth or nose when someone with COVID-19 coughs, sneezes or even speaks moistly. The droplet size is on the order of human hair width, and the researchers examined frequently touched surfaces, such as door handles and smartphone touchscreens.

Using a mathematical model well established in the field of interface science, the drying time calculations showed ambient temperature, type of surface and relative humidity play critical roles. For example, higher ambient temperature helped to dry out the droplet faster and drastically reduced the chances of virus survival. In places with greater humidity, the droplet stayed on surfaces longer, and the virus survival chances improved.

The researchers determined the droplet drying time in different outdoor weather conditions and examined if this data connected to the growth rate of the COVID-19 pandemic. Researchers selected New York, Chicago, Los Angeles, Miami, Sydney and Singapore and plotted the growth rate of COVID-19 patients in these cities with the drying time of a typical droplet. In the cities with a larger growth rate of the pandemic, the drying time was longer.

“In a way, that could explain a slow or fast growth of the infection in a particular city. This may not be the sole factor, but definitely, the outdoor weather matters in the growth rate of the infection,” said Rajneesh Bhardwaj, one of the authors.

“Understanding virus survival in a drying droplet could be helpful for other transmissible diseases that spread through respiratory droplets, such as influenza A,” said Amit Agrawal, another author.

The study suggests that surfaces, such as smartphone screens, cotton and wood, should be cleaned more often than glass and steel surfaces, because the latter surfaces are relatively hydrophilic, and the droplets evaporate faster on these surfaces.

###

The article, "Likelihood of survival of coronavirus in a respiratory droplet deposited on a solid surface," is authored by Rajneesh Bhardwaj and Amit Agrawal. The article will appear in Physics of Fluids on June 9, 2020 (DOI: 10.1063/5.0012009). After that date, it can be accessed at https://aip.scitation.org/doi/10.1063/5.0012009.

###

ABOUT THE JOURNAL

Physics of Fluids is devoted to the publication of original theoretical, computational, and experimental contributions to the dynamics of gases, liquids, and complex or multiphase fluids. See https://aip.scitation.org/journal/phf.

###

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.26025